(2020) confirmed aberrant METTL3 levels in the hippocampus of the Alzheimer's disease patients brain induced an epitranscriptomic mechanism, which resulted in the changes in related gene expression patterns in Alzheimer's disease. Here, METTL3 is linked to Alzheimer disease.